Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

@article{Vaery1988ElevatedCL,
  title={Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis},
  author={H. Vaer{\o}y and R. Helle and {\O}. F{\o}rre and E. Kass and L. Terenius},
  journal={Pain},
  year={1988},
  volume={32},
  pages={21-26}
}
&NA; In 30 patients with diagnosed fibromyalgia, the CSF level of immunoreactive substance P (SP) was investigated. Compared to normal values (9.6 ± 3.2 fmol/ml), all the patients had elevated CSF levels of SP (36.1 ± 2.7 fmol/ml, range 16.5–79.1 fmol/ml). Anamnestic information from the patients revealed that 53.3% had Raynaud/Raynaud‐like phenomenon localized in the fingers, the toes or both. Although SP levels did not differ significantly in patients with or without the Raynaud phenomenon… Expand
Fibromyalgia - symptom or diagnosis: A definition of the position
  • D. Sievers
  • Medicine
  • Scandinavian journal of rheumatology. Supplement
  • 2000
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Substance P in the Nervous System
Influence of substance P on nociception and stress.
Opioid control of the function of primary afferent substance P fibres.
...
1
2
3
...